Medicare Part D prescription drug plans should not prevent pharmacies from telling customers when they could pay less for a drug by paying cash, the Centers for Medicare & Medicaid Services told plan sponsors yesterday. “An important step in putting patients first and lowering out-of-pocket costs is addressing ‘gag clauses’ that some health plans and pharmacy benefit managers include in their contracts with pharmacies,” the memo states. “…We want to make it clear that CMS finds any form of ‘gag clauses’ unacceptable and contrary to our efforts to promote drug price transparency and lower drug prices. We also remind Part D plan sponsors that they must require their network pharmacies to disclose any differential between the price of a Part D drug and the price of the lowest cost therapeutically-equivalent generic version of that Part D drug.”

Related News Articles

Headline
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the…
Headline
The Department of Health and Human Services as of July 1 has reduced by nearly 20% its backlog of Medicare appeals at the Administrative Law Judge level,…
Headline
The Centers for Medicare & Medicaid Services this week released final Medicare Advantage data on services provided to beneficiaries in calendar year 2015.
Headline
The House Energy and Commerce Committee today approved legislation to address surprise medical bills and Medicaid disproportionate share hospital cuts.
Headline
The Trump administration today withdrew a proposed rule that would eliminate the rebate safe harbor for pharmacy benefit managers under the federal anti-…
Headline
A federal judge yesterday struck down a Centers for Medicare…